Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Long-Term Investments (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Long-Term Investments for 3 consecutive years, with $3.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Long-Term Investments fell 80.93% year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Jun 2025, down 80.93%, and an annual FY2024 reading of $11.6 million, changed 0.3% over the prior year.
  • Long-Term Investments was $3.4 million for Q2 2025 at SBC Medical Group Holdings, down from $11.6 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $120.4 million in Q1 2023 and bottomed at $3.4 million in Q2 2025.
  • Average Long-Term Investments over 3 years is $27.8 million, with a median of $11.7 million recorded in 2024.
  • Peak annual rise in Long-Term Investments hit 0.3% in 2024, while the deepest fall reached 85.06% in 2024.
  • Year by year, Long-Term Investments stood at $11.5 million in 2023, then rose by 0.3% to $11.6 million in 2024, then plummeted by 70.18% to $3.4 million in 2025.
  • Business Quant data shows Long-Term Investments for SBC at $3.4 million in Q2 2025, $11.6 million in Q4 2024, and $11.7 million in Q3 2024.